The Impact of Microbiota‐Mediated Immune Regulation on Recurrent Pregnancy Loss and Intervention Strategies
American Journal of Reproductive Immunology · 2025
DOI: 10.1111/aji.70121 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, 2025. Verfasst von Yao Yao und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Abortion, Habitual, Gastrointestinal Microbiome, Dysbiosis, Microbiota. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 104 Literaturangaben. Gefördert von: Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Recurrent pregnancy loss (RPL) significantly affects reproductive health in couples of childbearing age. Its pathogenesis is complex, with nearly 50% of cases remaining unexplained, and immune regulation plays a key role in its development. This review focuses on the relationship between human microbiota (gut, reproductive tract, and endometrial microbiota), immune regulation, and RPL, systematically summarizing related research progress. RPL patients exhibit characteristic changes in the gut, reproductive tract, and endometrial microbiota, such as reduced gut microbial diversity, decreased beneficial bacteria, increased harmful bacteria in the reproductive tract, and an imbalanced endometrial microbiota structure. Dysbiosis can lead to immune regulation abnormalities, increasing the risk of RPL by disrupting immune tolerance, triggering inflammatory responses, and interfering with metabolism. Although microbiota‐based interventions, such as probiotics, prebiotics, and fecal microbiota transplantation, show potential, they face challenges related to strain selection, donor screening, and unclear mechanisms. Current research also faces limitations in detection technology and sample size, and the understanding of the microbiota‐immune‐RPL relationship requires further deepening. Future studies should clarify causal relationships using advanced technologies, develop more effective detection and intervention methods, and create personalized treatment plans based on individual patient characteristics to improve clinical diagnosis and treatment of RPL and safeguard women's reproductive health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, Women's Hospital School of Medicine, Zhejiang University, Hangzhou, China.
ORCID-Profile: Yao Yao, Yiqing Ye, Caihong Zheng
Förderung
- Huadong Medicine Joint Funds of the Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Yao, Y., Ye, Y., & Zheng, C. (2025). The Impact of Microbiota‐Mediated Immune Regulation on Recurrent Pregnancy Loss and Intervention Strategies. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70121
Vancouver
Yao Y, Ye Y, Zheng C. The Impact of Microbiota‐Mediated Immune Regulation on Recurrent Pregnancy Loss and Intervention Strategies. American Journal of Reproductive Immunology. 2025. doi:10.1111/aji.70121
BibTeX
@article{Yao2025,
author = {Yao, Yao and Ye, Yiqing and Zheng, Caihong},
title = {The Impact of Microbiota‐Mediated Immune Regulation on Recurrent Pregnancy Loss and Intervention Strategies},
journal = {American Journal of Reproductive Immunology},
year = {2025},
doi = {10.1111/aji.70121}
}
EUVIMED